S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3‐mediated programmed death‐ligand 1 expression in colorectal cancer-Reference-Cited by-同舟云学术

S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3‐mediated programmed death‐ligand 1 expression in colorectal cancer

Published:2022-07 Issue:7 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Min Hye‐Young¹²,Cho Jaebeom¹²,Sim Jeong Yeon¹,Boo Hye‐Jin¹²,Lee Ji‐Sun¹,Lee Seon‐Boon³,Lee Young‐Jin³,Kim Sung Joo⁴,Kim Kyu‐Pyo⁵,Park In‐Ja⁶,Hong Seung‐Mo⁴,Zhang Xue‐Li⁷,Zhang Zhi‐Gang⁷^ORCID,Park Rang‐Woon³,Lee Ho‐Young¹²^ORCID

Affiliation:

1. Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy Seoul National University Seoul Republic of Korea

2. College of Pharmacy and Research Institute of Pharmaceutical Sciences Seoul National University Seoul Republic of Korea

3. Department of Biochemistry and Cell Biology, School of Medicine, Cell & Matrix Research Institute Kyungpook National University Daegu Republic of Korea

4. Department of Pathology, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

5. Department of Oncology, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

6. Department of Surgery, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

7. State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai P.R. China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.986

Reference71 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Prediction of Cancer Incidence and Mortality in Korea, 2021

3. FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms

4. Advances in immunotherapy for colorectal cancer: a review

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic impact of programmed death – 1 in the treatment of colorectal cancer;Pathology - Research and Practice;2024-07

2. Challenges and opportunities for cancer stem cell‐targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell‐dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes;Journal of Biochemical and Molecular Toxicology;2024-05-19

3. Identification and validation of three potential biomarkers and immune microenvironment for in severe asthma in microarray and single-cell datasets;Journal of Asthma;2024-05-07

4. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs;Experimental Hematology & Oncology;2024-01-22

5. HOXC6: A promising biomarker linked to an immunoevasive microenvironment in colorectal cancer based on TCGA analysis and cohort validation;Heliyon;2024-01